Screener
Praxis Precision Medicines, Inc. PRAX Intangibles (Net)
Intangibles (Net) at other companies
Other financials
Where this comes from
Reported directly by Praxis Precision Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.
The source filing: Praxis Precision Medicines, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:32 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001689548-26-000083
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Long-term marketable securities | 615,290 | 326,757 |
| Property and equipment, net | 492 | 147 |
| Operating lease right-of-use assets | 1,001 | 92 |
| Internal-use software | 773 | — |
| Other assets | 643 | — |
| Total assets | $1,390,102 | $937,907 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Praxis Precision Medicines, Inc.'s intangibles (net)?
- Praxis Precision Medicines, Inc. (PRAX) reported intangibles (net) of $773K in Q2 2026.
- What does intangibles (net) mean?
- Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.
Ask your AI about Praxis Precision Medicines, Inc.'s intangibles (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude